Transient Combination Therapy Targeting the Immune Synapse Abrogates T Cell Responses and Prolongs Allograft Survival in Mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transient Combination Therapy Targeting the Immune Synapse Abrogates T Cell Responses and Prolongs Allograft Survival in Mice
Authors
Keywords
T cells, Skin grafting, Cytotoxic T cells, Regulatory T cells, Spleen, Lymph nodes, Adoptive transfer, Immune response
Journal
PLoS One
Volume 8, Issue 7, Pages e69397
Publisher
Public Library of Science (PLoS)
Online
2013-07-25
DOI
10.1371/journal.pone.0069397
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-TCRβ mAb Induces Long-Term Allograft Survival by Reducing Antigen-Reactive T Cells and Sparing Regulatory T Cells
- (2012) Y. Miyahara et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Fatal PML associated with efalizumab therapy: Insights into integrin L 2 in JC virus control
- (2012) N. Schwab et al. NEUROLOGY
- LFA-1 Antagonism Inhibits Early Infiltration of Endogenous Memory CD8 T Cells into Cardiac Allografts and Donor-Reactive T Cell Priming
- (2011) K. Setoguchi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Fates of CD4+ T Cells in a Tolerant Environment Depend on Timing and Place of Antigen Exposure
- (2011) B. E. Burrell et al. AMERICAN JOURNAL OF TRANSPLANTATION
- LFA-1 blockade induces effector and regulatory T-cell enrichment in lymph nodes and synergizes with CTLA-4Ig to inhibit effector function
- (2011) N. M. Reisman et al. BLOOD
- T Cell Receptor Internalization from the Immunological Synapse Is Mediated by TC21 and RhoG GTPase-Dependent Phagocytosis
- (2011) Nuria Martínez-Martín et al. IMMUNITY
- Integrin antagonists for transplant immunosuppression: panacea or peril?
- (2011) William H Kitchens et al. Immunotherapy
- Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients
- (2010) R. Ferguson et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Experience with a Novel Efalizumab-Based Immunosuppressive Regimen to Facilitate Single Donor Islet Cell Transplantation
- (2010) N. A. Turgeon et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti-LFA-1 Antibody Efalizumab
- (2010) A. M. Posselt et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Advances in immunosuppression for renal transplantation
- (2010) Antoine Durrbach et al. Nature Reviews Nephrology
- T10B9 monoclonal antibody: A short-acting nonstimulating monoclonal antibody that spares γδ T-cells and treats and prevents cellular rejection
- (2010) Thomas Waid Drug Design Development and Therapy
- Functional Anatomy of T Cell Activation and Synapse Formation
- (2009) David R. Fooksman et al. Annual Review of Immunology
- LFA-1 Affinity Regulation Is Necessary for the Activation and Proliferation of Naive T Cells
- (2009) Yang Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project
- (2009) Kenneth R Carson et al. LANCET ONCOLOGY
- Complete but curtailed T-cell response to very low-affinity antigen
- (2009) Dietmar Zehn et al. NATURE
- What's Next in the Pipeline
- (2008) F. Vincenti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune Destruction
- (2008) Qizhi Tang et al. IMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More